PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER

PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER was reported 542 times

PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FACTOR XA ACTIVITY INCREASED 1 0.0455
1 PRODUCT PREPARATION ISSUE 184 0.0280
2 IMMATURE GRANULOCYTE PERCENTAGE INCREASED 1 0.0164
3 PRODUCT CLOSURE ISSUE 7 0.0126
4 INTRACARDIAC PRESSURE INCREASED 1 0.0114
5 MEDICAL DEVICE SITE THROMBOSIS 1 0.0097
6 SERRATIA SEPSIS 1 0.0093
7 HYPERTROPHIC SCAR 1 0.0092
8 FASCIOTOMY 1 0.0089
9 TRAUMATIC SHOCK 1 0.0087
10 ANTI FACTOR VIII ANTIBODY INCREASED 1 0.0081
11 EPIDURAL HAEMORRHAGE 1 0.0077
12 TISSUE INFILTRATION 2 0.0068
13 HEPATIC ISCHAEMIA 2 0.0064
14 PRODUCT RECONSTITUTION ISSUE 2 0.0063
15 COSTOVERTEBRAL ANGLE TENDERNESS 1 0.0061
16 FACTOR VIII DEFICIENCY 1 0.0056
17 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
18 GENERAL PHYSICAL CONDITION DECREASED 1 0.0053
19 INFUSION SITE NECROSIS 1 0.0052
20 EXPOSURE TO UNSPECIFIED AGENT 1 0.0051
21 HAEMOGLOBIN 1 0.0050
22 NECROTISING SOFT TISSUE INFECTION 1 0.0043
23 INFUSION SITE THROMBOSIS 1 0.0037
24 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
25 RENAL ARTERY OCCLUSION 1 0.0036
26 CATHETER SITE THROMBOSIS 1 0.0036
27 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
28 WRONG PRODUCT STORED 1 0.0035
29 MEDICAL DEVICE SITE HAEMORRHAGE 1 0.0035
30 INFUSION SITE EXTRAVASATION 21 0.0034
31 RENAL ARTERY THROMBOSIS 1 0.0032
32 ADMINISTRATION SITE SWELLING 1 0.0031
33 PACKAGING DESIGN ISSUE 1 0.0030
34 CEREBRAL AMYLOID ANGIOPATHY 1 0.0030
35 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
36 PROTHROMBIN LEVEL INCREASED 1 0.0029
37 ADMINISTRATION SITE BRUISE 1 0.0029
38 MONOCYTE PERCENTAGE INCREASED 2 0.0028
39 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
40 EXTRAVASATION 11 0.0027
41 BRAIN COMPRESSION 1 0.0025
42 CRANIOTOMY 1 0.0024
43 RED BLOOD CELL TRANSFUSION 1 0.0024
44 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 3 0.0024
45 DEVICE ISSUE 211 0.0024
46 PELVIC HAEMATOMA 1 0.0023
47 SPLENIC HAEMORRHAGE 1 0.0020
48 PROCEDURAL SITE REACTION 1 0.0019
49 INFUSION SITE VESICLES 1 0.0019
50 DEVICE CONNECTION ISSUE 4 0.0019
51 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
52 HAEMORRHAGIC INFARCTION 1 0.0018
53 HAEMORRHAGIC OVARIAN CYST 1 0.0017
54 DOSE CALCULATION ERROR 1 0.0017
55 PNEUMONIA NECROTISING 1 0.0015
56 EMBOLIC CEREBRAL INFARCTION 1 0.0015
57 SILENT MYOCARDIAL INFARCTION 1 0.0015
58 ABSCESS NECK 1 0.0015
59 BRAIN CANCER METASTATIC 1 0.0014
60 INFUSION SITE INFLAMMATION 1 0.0014
61 THROMBOTIC STROKE 1 0.0014
62 NO ADVERSE EVENT 237 0.0013
63 PULMONARY ARTERY THROMBOSIS 1 0.0013
64 COAGULATION TEST ABNORMAL 1 0.0013
65 CRITICAL ILLNESS 1 0.0013
66 METAPNEUMOVIRUS INFECTION 1 0.0013
67 AORTIC DISORDER 1 0.0013
68 PRODUCT LABEL CONFUSION 7 0.0012
69 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
70 INFUSION SITE OEDEMA 1 0.0012
71 CEREBELLAR INFARCTION 2 0.0012
72 INFUSION SITE DISCOLOURATION 1 0.0011
73 EMBOLIC STROKE 4 0.0011
74 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
75 ANAEMIA OF CHRONIC DISEASE 1 0.0011
76 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
77 INTESTINAL INFARCTION 1 0.0011
78 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
79 PRODUCT APPEARANCE CONFUSION 1 0.0011
80 BRAIN STEM HAEMORRHAGE 1 0.0011
81 WRONG SCHEDULE 1 0.0010
82 ACQUIRED HAEMOPHILIA 1 0.0010
83 INFUSION SITE DISCOMFORT 1 0.0010
84 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
85 CEREBRAL ARTERY OCCLUSION 1 0.0009
86 INFUSION SITE MASS 1 0.0009
87 PRODUCT SELECTION ERROR 1 0.0009
88 CEREBRAL HAEMATOMA 3 0.0009
89 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
90 BLOOD FIBRINOGEN DECREASED 1 0.0009
91 PUPILS UNEQUAL 1 0.0009
92 CARBON DIOXIDE DECREASED 1 0.0009
93 EMBOLISM 7 0.0008
94 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
95 PRODUCT PACKAGING CONFUSION 2 0.0008
96 INFUSION SITE WARMTH 1 0.0008
97 INFUSION SITE SWELLING 5 0.0008
98 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
99 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
100 COMPARTMENT SYNDROME 2 0.0008
101 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
102 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
103 INTESTINAL MASS 1 0.0007
104 ISCHAEMIC HEPATITIS 1 0.0007
105 INFUSION SITE RASH 1 0.0007
106 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
107 CEREBELLAR HAEMORRHAGE 1 0.0007
108 GASTROINTESTINAL NECROSIS 2 0.0007
109 BRAIN HERNIATION 2 0.0007
110 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
111 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
112 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
113 EMERGENCY CARE 2 0.0007
114 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
115 INHIBITORY DRUG INTERACTION 1 0.0006
116 SPLENIC RUPTURE 1 0.0006
117 VENA CAVA THROMBOSIS 1 0.0006
118 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
119 PUPIL FIXED 1 0.0006
120 SPLENIC INFARCTION 1 0.0006
121 CEREBRAL INFARCTION 14 0.0006
122 JUGULAR VEIN THROMBOSIS 1 0.0006
123 INTESTINAL ISCHAEMIA 3 0.0005
124 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
125 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
126 SHOCK HAEMORRHAGIC 4 0.0005
127 INJECTION SITE EXTRAVASATION 6 0.0005
128 VENOUS THROMBOSIS LIMB 1 0.0005
129 DEVICE LEAKAGE 21 0.0005
130 ATRIAL THROMBOSIS 1 0.0005
131 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
132 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
133 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
134 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
135 VASCULAR OCCLUSION 1 0.0005
136 HAEMORRHAGE INTRACRANIAL 7 0.0005
137 INFUSION SITE BRUISING 1 0.0005
138 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
139 BLOOD LOSS ANAEMIA 1 0.0004
140 ISCHAEMIA 2 0.0004
141 SUBDURAL HAEMATOMA 6 0.0004
142 RETROPERITONEAL HAEMORRHAGE 1 0.0004
143 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
144 SYSTEMIC CANDIDA 1 0.0004
145 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
146 HAEMORRHAGE URINARY TRACT 1 0.0004
147 CEREBRAL ISCHAEMIA 2 0.0004
148 SUBDURAL HAEMORRHAGE 1 0.0004
149 ENDOTRACHEAL INTUBATION 1 0.0004
150 PRODUCT LEAKAGE 2 0.0004
151 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
152 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
153 BLOOD CULTURE POSITIVE 1 0.0003
154 METABOLIC ENCEPHALOPATHY 1 0.0003
155 INTRACARDIAC THROMBUS 1 0.0003
156 BRAIN DEATH 1 0.0003
157 PORTAL VEIN THROMBOSIS 1 0.0003
158 DEEP VEIN THROMBOSIS 20 0.0003
159 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
160 COAGULOPATHY 5 0.0003
161 PRODUCT LABEL ISSUE 2 0.0003
162 SUBARACHNOID HAEMORRHAGE 3 0.0003
163 ECCHYMOSIS 2 0.0003
164 DEVICE DEFECTIVE 5 0.0003
165 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
166 NECROTISING FASCIITIS 1 0.0003
167 FIBRIN D DIMER INCREASED 1 0.0003
168 ISCHAEMIC STROKE 5 0.0003
169 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
170 VENTRICULAR ARRHYTHMIA 1 0.0003
171 ACUTE MYOCARDIAL INFARCTION 8 0.0003
172 HYDRONEPHROSIS 2 0.0003
173 HAEMODYNAMIC INSTABILITY 2 0.0003
174 PROCEDURAL HAEMORRHAGE 1 0.0003
175 CEREBRAL HAEMORRHAGE 9 0.0003
176 PERIPHERAL ISCHAEMIA 1 0.0002
177 HEMIPLEGIA 2 0.0002
178 PRODUCT CONTAINER ISSUE 2 0.0002
179 DEVICE OPERATIONAL ISSUE 1 0.0002
180 PYELONEPHRITIS 2 0.0002
181 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
182 VASCULAR DEVICE INFECTION 1 0.0002
183 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
184 INTERCEPTED MEDICATION ERROR 1 0.0002
185 PULSE ABSENT 1 0.0002
186 HYPOVOLAEMIC SHOCK 1 0.0002
187 PANCREATIC DISORDER 1 0.0002
188 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
189 STAPHYLOCOCCAL SEPSIS 1 0.0002
190 ENDOCARDITIS 1 0.0002
191 SKIN NECROSIS 1 0.0002
192 BLOOD LACTIC ACID INCREASED 1 0.0002
193 CHOLECYSTITIS ACUTE 1 0.0002
194 PERONEAL NERVE PALSY 1 0.0002
195 INTERNAL HAEMORRHAGE 2 0.0002
196 CARDIAC VALVE DISEASE 1 0.0002
197 PROTHROMBIN TIME PROLONGED 1 0.0002
198 PLATELET COUNT ABNORMAL 1 0.0002
199 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
200 CHOLANGITIS 1 0.0002
201 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
202 INFUSION SITE PAIN 2 0.0002
203 UNRESPONSIVE TO STIMULI 4 0.0002
204 MENINGITIS 1 0.0001
205 COLITIS ISCHAEMIC 1 0.0001
206 PULMONARY EMBOLISM 14 0.0001
207 PRODUCT PREPARATION ERROR 3 0.0001
208 PRODUCT DISPENSING ERROR 3 0.0001
209 THROMBOSIS 11 0.0001
210 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
211 CEREBRAL DISORDER 1 0.0001
212 HAEMORRHAGE 14 0.0001
213 APHASIA 4 0.0001
214 DEVICE FAILURE 2 0.0001
215 HAEMORRHAGIC STROKE 1 0.0001
216 PRODUCT USE COMPLAINT 2 0.0001
217 SENSORY LOSS 1 0.0001
218 ACUTE CORONARY SYNDROME 1 0.0001
219 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
220 INFUSION SITE ERYTHEMA 1 0.0001
221 HAEMATURIA 4 0.0001
222 PRODUCT COMMUNICATION ISSUE 1 0.0001
223 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
224 CARDIAC ARREST 9 0.0001
225 MENTAL STATUS CHANGES 3 0.0001
226 DRUG PRESCRIBING ERROR 2 0.0001
227 ATELECTASIS 1 0.0001
228 HAEMATOCRIT DECREASED 2 0.0001
229 BRAIN INJURY 1 0.0001
230 INJURY ASSOCIATED WITH DEVICE 2 0.0001
231 POOR VENOUS ACCESS 1 0.0001
232 PERITONITIS 2 0.0001
233 PETECHIAE 1 0.0001
234 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
235 SCRATCH 1 0.0001
236 SUDDEN DEATH 1 0.0001
237 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
238 SKIN LACERATION 1 0.0001
239 SEPTIC SHOCK 4 0.0001
240 VENTRICULAR FIBRILLATION 1 0.0001
241 HEPATITIS C 1 0.0001
242 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
243 PNEUMONIA ASPIRATION 2 0.0001
244 BRAIN OEDEMA 1 0.0001
245 MYDRIASIS 1 0.0001
246 GENITAL HAEMORRHAGE 1 0.0001
247 HAEMATOMA 2 0.0001
248 DEVICE BREAKAGE 3 0.0001
249 LIMB INJURY 2 0.0001
250 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
251 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
252 DIVERTICULITIS 2 0.0001
253 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
254 CARPAL TUNNEL SYNDROME 1 0.0001
255 DEVICE MALFUNCTION 5 0.0001
256 CEREBROVASCULAR ACCIDENT 12 0.0001
257 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
258 BRONCHOSPASM 1 0.0001
259 CARDIOGENIC SHOCK 1 0.0001
260 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
261 FLUID OVERLOAD 1 0.0001
262 PULMONARY MASS 1 0.0001
263 HEPATIC FAILURE 2 0.0001
264 DRUG DISPENSING ERROR 1 0.0001
265 DRUG ADMINISTRATION ERROR 2 0.0001
266 PHARYNGEAL OEDEMA 1 0.0001
267 HYPOTENSION 13 0.0001
268 ULCER 1 0.0001
269 VENTRICULAR TACHYCARDIA 1 0.0001
270 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
271 EXPIRED PRODUCT ADMINISTERED 2 0.0001
272 CANDIDA INFECTION 1 0.0001
273 HEMIPARESIS 1 0.0001
274 CIRCULATORY COLLAPSE 1 0.0001
275 LYMPHOCYTE COUNT DECREASED 1 0.0001
276 ANAPHYLACTIC REACTION 3 0.0001
277 BLOOD URINE PRESENT 1 0.0001
278 POST PROCEDURAL COMPLICATION 1 0.0001
279 CYTOKINE RELEASE SYNDROME 1 0.0000
280 PRODUCT ADMINISTRATION ERROR 1 0.0000
281 EXTRA DOSE ADMINISTERED 2 0.0000
282 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
283 PULMONARY HYPERTENSION 1 0.0000
284 HALLUCINATION, VISUAL 1 0.0000
285 LIVER FUNCTION TEST INCREASED 1 0.0000
286 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
287 PRODUCT PRESCRIBING ISSUE 1 0.0000
288 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
289 MELAENA 1 0.0000
290 ANGIOEDEMA 2 0.0000
291 SHOCK 1 0.0000
292 PRODUCT PRESCRIBING ERROR 1 0.0000
293 LIVER INJURY 1 0.0000
294 HAEMATEMESIS 1 0.0000
295 EXPOSURE VIA SKIN CONTACT 1 0.0000
296 THROAT TIGHTNESS 1 0.0000
297 OEDEMA 2 0.0000
298 RESPIRATORY ARREST 1 0.0000
299 HAEMATOCHEZIA 2 0.0000
300 MEDICATION ERROR 2 0.0000
301 SEPSIS 4 0.0000
302 HAEMOPTYSIS 1 0.0000
303 OXYGEN SATURATION DECREASED 2 0.0000
304 TARDIVE DYSKINESIA 1 0.0000
305 RED BLOOD CELL COUNT DECREASED 1 0.0000
306 NEEDLE ISSUE 1 0.0000
307 URINARY INCONTINENCE 1 0.0000
308 RESPIRATORY DISORDER 1 0.0000
309 BLOOD POTASSIUM DECREASED 1 0.0000
310 ACUTE KIDNEY INJURY 5 0.0000
311 PERIPHERAL SWELLING 5 0.0000
312 NERVOUS SYSTEM DISORDER 1 0.0000
313 NIGHT SWEATS 1 0.0000
314 BLOOD PRESSURE DECREASED 2 0.0000
315 FUNGAL INFECTION 1 0.0000
316 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
317 HAEMOGLOBIN DECREASED 3 0.0000
318 BURNING SENSATION 2 0.0000
319 HYPOXIA 1 0.0000
320 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
321 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
322 UNDERDOSE 2 0.0000
323 ACCIDENTAL OVERDOSE 1 0.0000
324 INJECTION SITE MASS 1 0.0000
325 THROMBOCYTOPENIA 3 0.0000
326 DYSARTHRIA 1 0.0000
327 INTESTINAL OBSTRUCTION 1 0.0000
328 ANAEMIA 5 0.0000
329 INJECTION SITE SWELLING 2 0.0000
330 DISORIENTATION 1 0.0000
331 CARDIAC FAILURE 2 0.0000
332 CONFUSIONAL STATE 4 0.0000
333 NEUTROPHIL COUNT DECREASED 1 0.0000
334 CARDIO-RESPIRATORY ARREST 1 0.0000
335 ROAD TRAFFIC ACCIDENT 1 0.0000
336 RECTAL HAEMORRHAGE 1 0.0000
337 MYOCARDIAL INFARCTION 4 0.0000
338 PULMONARY OEDEMA 1 0.0000
339 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
340 PRODUCT QUALITY ISSUE 3 0.0000
341 INCORRECT DOSE ADMINISTERED 5 0.0000
342 SKIN DISCOLOURATION 1 0.0000
343 COGNITIVE DISORDER 1 0.0000
344 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
345 SWELLING 2 0.0000
346 COMA 1 0.0000
347 INTERSTITIAL LUNG DISEASE 1 0.0000
348 ATRIAL FIBRILLATION 2 0.0000
349 HYPOAESTHESIA 3 0.0000
350 CELLULITIS 1 0.0000
351 FLUSHING 2 0.0000
352 SPEECH DISORDER 1 0.0000
353 DRUG INTERACTION 3 0.0000
354 BRADYCARDIA 1 0.0000
355 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
356 PLATELET COUNT DECREASED 2 0.0000
357 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
358 EYE PAIN 1 0.0000
359 EYE IRRITATION 1 0.0000
360 CHILLS 2 0.0000
361 PLEURAL EFFUSION 1 0.0000
362 FEELING HOT 1 0.0000
363 HYPERSENSITIVITY 3 0.0000
364 BLOOD CREATININE INCREASED 1 0.0000
365 DEVICE DIFFICULT TO USE 1 0.0000
366 FALL 5 0.0000
367 OFF LABEL USE 13 0.0000
368 NEUTROPENIA 2 0.0000
369 HEPATIC ENZYME INCREASED 1 0.0000
370 DRUG INEFFECTIVE 19 0.0000
371 OVERDOSE 3 0.0000
372 RESPIRATORY FAILURE 1 0.0000
373 CHRONIC KIDNEY DISEASE 1 0.0000
374 HOSPITALISATION 2 0.0000
375 ABDOMINAL PAIN 3 0.0000
376 DRUG ABUSE 1 0.0000
377 SKIN EXFOLIATION 1 0.0000
378 URINARY TRACT INFECTION 2 0.0000
379 PRODUCT STORAGE ERROR 1 0.0000
380 MUSCULOSKELETAL STIFFNESS 1 0.0000
381 TACHYCARDIA 1 0.0000
382 GASTROINTESTINAL DISORDER 1 0.0000
383 CHEST PAIN 2 0.0000
384 PAIN IN EXTREMITY 3 0.0000
385 SYNCOPE 1 0.0000
386 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
387 WEIGHT INCREASED 2 0.0000
388 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
389 PALPITATIONS 1 0.0000
390 EMOTIONAL DISTRESS 1 0.0000
391 OEDEMA PERIPHERAL 1 0.0000
392 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
393 VISUAL IMPAIRMENT 1 0.0000
394 INJECTION SITE ERYTHEMA 1 0.0000
395 RENAL FAILURE 1 0.0000
396 DYSPNOEA 4 0.0000
397 ANXIETY 2 0.0000
398 RASH 3 0.0000
399 HEADACHE 4 0.0000
400 PARAESTHESIA 1 0.0000
401 PNEUMONIA 2 0.0000
402 TREMOR 1 0.0000
403 PYREXIA 2 0.0000
404 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
405 PRODUCT USE ISSUE 1 0.0000
406 BLOOD GLUCOSE INCREASED 1 0.0000
407 GAIT DISTURBANCE 1 0.0000
408 PAIN 3 0.0000
409 ERYTHEMA 1 0.0000
410 DIZZINESS 2 0.0000
411 DEATH 3 0.0000
412 PRODUCT DOSE OMISSION ISSUE 1 0.0000
413 CONDITION AGGRAVATED 1 0.0000
414 ASTHENIA 1 0.0000
415 FATIGUE 1 0.0000